Supernus Pharma (SUPN) Tops Q3 EPS by 3c

Supernus Pharma (NASDAQ: SUPN) reported Q3 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $52.5 million versus the consensus estimate of $43.1 million.

For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Trump discloses over $1.4 billion in crypto income in 2025 filing
• JPMorgan Reinstates Adidas AG (ADS:GR) (ADDYY) at Overweight